Your session is about to expire
← Back to Search
Psychotherapy for PTSD and Substance Use Disorders (COMPASS Trial)
COMPASS Trial Summary
This trial will compare two types of psychotherapy, one focused on the trauma and one not, to see which is better for treating PTSD in patients who also have substance use disorders.
COMPASS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCOMPASS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.COMPASS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Start outpatient treatment for addiction at a facility that participates in the program.You have been diagnosed with PTSD.You currently have a substance use disorder, as defined by the DSM-5. Just smoking tobacco alone is not enough to be included in the study.You need to tell us if you have used any drugs or alcohol in the past month or if you will be leaving a controlled environment before joining the trial.and for 12 months following the last dose of study drug
agree not to receive any non-study active psychotherapy for PTSD during the study treatment and for the 12 months following the last dose of the study drug.You have thoughts of hurting yourself or someone else and have a specific plan to do so.You have unstable symptoms of psychosis or mania that are not related to substance abuse.You currently have a substance use disorder, which means you have a problem with drugs or alcohol (excluding tobacco use disorder alone).You need to disclose if you have used drugs or alcohol in the last 30 days or before entering a controlled environment, if you are leaving that environment at the time of enrollment.You have significant problems with thinking or memory.
- Group 1: Trauma-Focused Therapy
- Group 2: Non-Trauma-Focused Therapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you please provide an estimate of the number of locations currently engaged in this research trial?
"Currently, 14 different facilities are enrolling participants for this research. These locations span across Salt Lake City, Cleveland and Seattle; with many other centres available to choose from in order to reduce the need for travel when participating in the study."
How extensive is the population enrolled in this research endeavor?
"This clinical trial demands 420 eligible participants that abide by the inclusion criteria. Salt Lake City VA Healthcare System and Louis Stokes Cleveland VA Medical Center are two of many participating sites located in different cities."
Are there still spots available for this research trial?
"According to the information available from clinicaltrials.gov, recruitment for this trial is taking place now. It was first posted on December 8th 2020 and has had its parameters updated as recently as April 30th 2021."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger